- Home
- OLMA vs UEC Comparison
OLMA vs UEC Comparison
Compare OLMA & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLMA | UEC |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 5.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OLMA | UEC |
|---|---|---|
| Price | $26.97 | $18.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $41.14 | $15.80 |
| AVG Volume (30 Days) | 1.5M | ★ 11.3M |
| Earning Date | 11-10-2025 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $49,750,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $153.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 189.19 |
| 52 Week Low | $2.86 | $3.85 |
| 52 Week High | $36.26 | $18.72 |
Technical Indicators
Market Signals| Indicator | OLMA | UEC |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 78.77 |
| Support Level | $26.93 | $15.10 |
| Resistance Level | $29.50 | $18.72 |
| Average True Range (ATR) | 1.56 | 1.07 |
| MACD | -0.28 | 0.50 |
| Stochastic Oscillator | 41.06 | 97.01 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About UEC Uranium Energy Corp.
Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.